Compass Therapeutics Inc. (CMPX)
NASDAQ: CMPX
· Real-Time Price · USD
2.35
-0.02 (-0.84%)
At close: Jun 17, 2025, 10:37 AM
-0.84% (1D)
| Bid | 2.35 |
| Market Cap | 325.66M |
| Revenue (ttm) | 3.69M |
| Net Income (ttm) | -47.76M |
| EPS (ttm) | -0.4 |
| PE Ratio (ttm) | -5.89 |
| Forward PE | -4.31 |
| Analyst | Buy |
| Ask | 2.36 |
| Volume | 88,150 |
| Avg. Volume (20D) | 1,428,173 |
| Open | 2.38 |
| Previous Close | 2.37 |
| Day's Range | 2.30 - 2.42 |
| 52-Week Range | 0.77 - 4.08 |
| Beta | 1.22 |
About CMPX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMPX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+17.89%
Compass Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
3 months ago
+6.51%
Compass Therapeutics shares are trading higher after Guggenhiem initiated coverage on the stock with a Buy rating and announced a price target of $12.
6 days ago · https://www.defenseworld.net
Squarepoint Ops LLC Acquires New Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX)Squarepoint Ops LLC acquired a new stake in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and...
